Screening centers squelch balanced information
Whole-body screening centers fail to provide balanced advertisements, often touting unsupported benefits while downplaying the known risks. Stanford University researchers say the industry needs better oversight to protect consumers.
Whole-body screening centers fail to provide balanced advertisements, often touting unsupported benefits while downplaying the known risks. Stanford University researchers say the industry needs better oversight to protect consumers.
Judy Illes, Ph.D., and colleagues analyzed scores of newspaper ads and brochures from screening centers across the country. They found an overall emphasis on information about healthcare technology, assurances of good health, and financial incentives to self-refer (Arch Intern Med 2004;164:2415-2419).
Some ads stoked fear of the consequences of not obtaining a scan, but references to the risk of radiation associated with CT were missing. Ads from these same companies for their MRI services made explicit reference to that modality's lack of radiation.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.
Study: Monitoring of Prostate MRI Exams Could Lead to 75 Percent Reduction of Gadolinium Contrast
March 17th 2025While DCE MRI was deemed helpful in over 67 percent of cases in which it was used, researchers found that monitored prostate MRI exams, which facilitated a 75 percent reduction of DCE MRI sequences, had comparable sensitivity for prostate cancer as non-monitored exams.
